Pfizer says antiviral pill cuts risk of severe Covid-19 by 89%

  By Reuters staff, published by Channel NewsAsia New York – A trial of Pfizer’s experimental antiviral pill for Covid-19 was stopped early after the drug was shown to cut by 89 per cent the chances of hospitalisation or death for adults at risk of developing severe disease, the company said today (Nov. 5). The

Read more